Biogen Inc (BIIB) — Technical state
As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Uptrend stack intact — Trades +11.1% vs the 50-day and +25.7% vs the 200-day average, 1.7% below the 52-week high and +71.3% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
- Trend: Biogen Inc trades 11.1% above its 50-day and 25.7% above its 200-day moving average. (as of 2026-11-04)
Biogen discovers, develops and sells medicines for neurological, immune and rare conditions, largely outside the AI-linked sectors the diary tracks. Its portfolio includes multiple sclerosis treatments such as Tecfidera and Tysabri, the Alzheimer's drug Leqembi, and biosimilar versions of established antibody therapies.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BIIB overview. Research diary readings, not advice.
Trades +11.1% vs the 50-day and +25.7% vs the 200-day average, 1.7% below the 52-week high and +71.3% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+5.4%
- vs 50-day+11.1%
- vs 200-day+25.7%
- 52-week band1.7% off the high · +71.3% off the low
- Streak1 consecutive up session
- 50-day crossprice crossed up through the 50-day 73 sessions ago
- Stochastic%K 84.4 · %D 72.2 · bull cross
Continue: the BIIB chart & overview · the signal board
FAQ · from the current data · as of 2026-11-04
Quick answers
What is the current Closelooknet signal on BIIB?
Uptrend stack intact — Trades +11.1% vs the 50-day and +25.7% vs the 200-day average, 1.7% below the 52-week high and +71.3% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is BIIB above its 50-day and 200-day moving averages?
As of 2026-11-04, Biogen Inc trades +11.1% above its 50-day and +25.7% above its 200-day average, with the 20-day +5.4% away.
How far is BIIB from its 52-week high?
1.7% below the 52-week high and 71.3% above the 52-week low, as of 2026-11-04.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNBV.HE Orion Oyj Bindustry
- ORNAV.HE Orion Oyj Aindustry
- SAN.PA Sanofi SAindustry
- AMGN Amgen Incindustry
- NVO Novo Nordisk A/Sindustry
- GILD Gilead Sciences Incindustry
- SNY Sanofi ADRindustry
- ABBV AbbVie Incindustry
- PFE Pfizer Incindustry
- 002422.SHE Sichuan Kelun Pharmaceutical Co Ltdindustry
- JNJ Johnson & Johnsonindustry
- BMY Bristol-Myers Squibb Companyindustry
- MRK Merck & Company Incindustry
- OGN Organon & Coindustry
- AZN AstraZeneca PLCindustry
- CMHC.SW COSMO N NVindustry
- TDOC Teladoc Incsector
- MRNA Moderna Incsector
- ENOV Enovis Corpsector